Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
World Journal of Cardiology
|
May 21, 2020
Comparative assessment of clinical profile and outcomes after primary percutaneous coronary intervention in young patients with single <i>vs</i> multivessel disease
Atif Sher Muhammad, Tariq Ashraf, Ayaz Mir, et al.
Clinical Case Reports
|
February 11, 2026
Delayed Ileal Perforation With Psoas Abscess and Fistulization Into the Inferior Vena Cava Post-Dilation and Curettage-A Case Report
Faiza Farooq, Bilal Aslam, Muhammad Hamza, et al.
Journal of the American College of Cardiology
|
September 2, 2025
Twice-A-Day CLOpidogrel vs Ticagrelor to Reduce Short-Term MACE after Primary PCI: The TADCLOT Trial
Abdul Hakeem, Jehangir Ali Shah, Rajesh Kumar, et al.
American Heart Journal
|
April 14, 2025
Rationale and design of the TADCLOT trial: A double blind randomized controlled trial comparing twice a day clopidogrel vs ticagrelor in reducing major cardiac events in patients with acute STEMI undergoing primary percutaneous coronary intervention
Abdul Hakeem, Jehangir Ali Shah, Rajesh Kumar, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
World Journal of Cardiology
|
May 21, 2020
Comparative assessment of clinical profile and outcomes after primary percutaneous coronary intervention in young patients with single <i>vs</i> multivessel disease
Atif Sher Muhammad, Tariq Ashraf, Ayaz Mir, et al.
Clinical Case Reports
|
February 11, 2026
Delayed Ileal Perforation With Psoas Abscess and Fistulization Into the Inferior Vena Cava Post-Dilation and Curettage-A Case Report
Faiza Farooq, Bilal Aslam, Muhammad Hamza, et al.
Journal of the American College of Cardiology
|
September 2, 2025
Twice-A-Day CLOpidogrel vs Ticagrelor to Reduce Short-Term MACE after Primary PCI: The TADCLOT Trial
Abdul Hakeem, Jehangir Ali Shah, Rajesh Kumar, et al.
American Heart Journal
|
April 14, 2025
Rationale and design of the TADCLOT trial: A double blind randomized controlled trial comparing twice a day clopidogrel vs ticagrelor in reducing major cardiac events in patients with acute STEMI undergoing primary percutaneous coronary intervention
Abdul Hakeem, Jehangir Ali Shah, Rajesh Kumar, et al.
Page
of 2